The real key is going to be side effects over time, if retatrutide is like other drugs in the class then the side effects should decrease with time, but unfortunately, we dont have that today, at this point I have some questions and minor concerns but without the data over time its hard to speculate about tolerability further beyond saying its similar to other drugs in the class
The hormone rebalancing underlies why GLP-1 therapy achieves greater weight loss maintenance than behavioral interventions alone
The lawsuit claims that Novo Nordisks and Eli Lillys: failure to disclose information that they possessed regarding the association between the use of GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues, including gastroparesis and gastroenteritis, rendered the warnings for this medication inadequate
As heart and metabolic diseases rise yearly, many people desire better health as soon as symptoms start showing up
At UCO Medical Clinic, patients can discuss medical weight-loss options with a licensed practitioner, review their health history, and leave with a clearly explained plan for follow-up